한글목차

세계의 데옥시콜산 주사 시장 미래는 병원 및 클리닉 시장에서의 기회로 유망시되고 있습니다. 세계의 데옥시콜산 주사 시장은 2025-2031년 연평균 복합 성장률(CAGR) 3.5%를 나타낼 것으로 전망됩니다. 이 시장의 주요 촉진요인은 비 수술 지방 감소에 대한 수요 증가, 미용 주사제의 인기 상승, 신체 윤곽 치료에 대한 인식 증가입니다.

• Lucintel의 예측에서 유형별로는 10mg/mL가 예측 기간 중 최대의 부문인 것을 계속합니다.
• 용도별로는 병원이 계속 큰 부문이 됩니다.
• 지역별로는 아시아태평양이 예측기간 중 가장 높은 성장을 이룰 전망입니다.

150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 얻으십시오. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.

데옥시콜산 주사 시장 새로운 동향

데옥시콜산 주사 시장은 낮은 침습적 접근에 대한 환자 수요, 기술, 치료 용도의 인지도 향상에 힘쓰고 빠르게 성장하고 있습니다. 이러한 추세는 향후 제품 개발, 임상 활동, 시장 개척에 영향을 미치고 보다 개별화되고 효율적인 조치로 향하는 경향이 있습니다.

• 적용 영역의 확대 : 데옥시콜산의 주사는 원래 턱밑 지방을 위한 것이었지만, 적응 외 사용으로서 다른 작은 지방 침착에도 자주 사용되고 있습니다. 이것은 "이중 턱" 이외에도 시장을 넓히고, 브래지어 팽창, 겨드랑 지방, 내퇴에 대한 비 수술 솔루션을 제공하며 환자에게보다 다목적이고 매력적입니다.
• 병용 요법 : 데옥시콜산 주사를 클라이오리포라이시스, 라디오 파, 또는 피부 타이트닝 치료와 같은 다른 미용 치료와 조합하여 사용하는 것에 대한 관심이 증가하고 있습니다. 이 병용 치료는 전반적인 지방 감소를 촉진하고 피부 이완을 강화하며 환자가 광범위하고 심미적으로 성공한 신체의 윤곽 형성 결과를 초래하는 시너지 효과를 갖도록 설계되었습니다.
• 제형의 기술 개발 : 데옥시콜산 주사의 제형을 개량하고, 효능을 높이고, 부작용을 경감하며, 환자의 쾌적성을 극대화하는 것을 목적으로 한 조사가 계속되고 있습니다. 약물 전달 기술의 개발과 새로운 활성 분자가 있는 경우 최소한의 치료 횟수로보다 타겟에 특화된 효과적인 지방 감소를 제공하기 위해 연구되고 있습니다.
• 개인화된 치료 계획 : 시장 동향은 복용량, 주입 방법 및 치료 횟수가 환자 고유의 해부학적 요구와 원하는 뷰티 목표에 맞춤화되는 매우 맞춤 치료 계획으로 전환하고 있습니다. 커스터마이징은 결과를 극대화하고, 환자 만족도를 높이고, 원치 않는 부작용의 가능성을 줄이고, 환자 본질 전략을 보여줍니다.
• 교육 및 교육의 중요성 : 적용 범위가 확대되고 새로운 방법이 개발됨에 따라, 시술자에 대한 광범위한 교육 및 교육이 중요해지고 있습니다. 이는 안전하고 효과적인 투여를 보장하고, 합병증의 발생을 최소화하고, 전체적인 환자 결과를 향상시킵니다.

이러한 동향은 데옥시콜산 주사 시장을보다 적응성이 높고 복합적이며 환자에 초점을 맞춘 방향으로 재구성하기 위해 집계되어 있습니다. 여러 부위의 치료, 다른 치료법과의 조합 가능성, 개별화된 계획의 제공은 더 큰 시장 확산과 치료 제공과 환자 결과에 대한 혁신을 창출합니다.

데옥시콜산 주사 시장 최근 동향

데옥시콜산 주사 시장은 치료 효과의 향상, 환자의 안전성, 보다 광범위한 이용가능성에 초점을 맞춘 혁신적인 진보에 의해 항상 개척되고 있습니다. 이들은 비침습적인 신체의 윤곽 형성에 대한 소비자의 관심 증가와 최고의 미적 결과의 추구에 대한 업계의 반응을 나타내는 지배적인 개발입니다.

• 새로운 적응을 위한 임상시험 확대 : 처음에는 턱밑 지방에 대해 승인되었지만, 임상시험의 확대는 다른 작은 지방침착에 대한 데옥시콜산의 사용을 고려하고 있습니다. 이 노력은 더 많은 치료 부위에 대한 규제 당국의 승인을 얻어 잠재적 시장을 턱 영역에만 머무르지 않고 크게 확장하고 더 많은 전신 윤곽 형성 솔루션을 제공하는 것을 목표로 합니다.
• 제형 및 전달 시스템 개발 : 기업은 더 나은 약동학 프로파일을 가진 데옥시콜산 제품 및 새로운 전달 시스템을 개발하기 위해 R&D에 투자하고 있습니다. 그 결과, 치료 후의 붓기가 적어지고, 작용 발현이 빨라지고, 주사 부위가 적어지는 등의 가능성이 있어, 최종적으로는 환자의 쾌적함과 만족도를 향상시켜, 시술자의 치료 프로세스를 간소화할 수 있습니다.
• 치료 계획을 위한 디지털 툴과 AI의 통합 : 인공지능과 디지털 이미징 툴의 사용은 데옥시콜산 주사의 치료 계획에서 큰 발전입니다. 이러한 기술은 지방 분포의 정확한 매핑을 가능하게 하고 치료 결과의 시뮬레이션을 시각화하여 주입 패턴을 최적화하여 더 높은 미적 결과와 환자의 이해와 기대를 제공합니다.
• 적응 외 사용의 출현과 의사의 전문 지식 : 초기에는 적응이 제한되어 있던 데옥시콜산 주사도 최근에는 베테랑 의사들 사이에서 적응 외의 데옥시콜산 주사를 채용하고, 모든 국소적인 감소의 요구에 대처하는 경향을 볼 수 있게 되었습니다. 의사의 전문 지식과 수요에 의해 자극되는이 진화는 제품의 실제 사용을 확장하고 안전 절차와 해부학 이해의 엄격한 검토를 요구합니다.
• 경쟁 시장 확대 및 제품 개척 : 한때는 단일 제품에 지배를 받았지만, 마켓플레이스는 다른 제약 회사의 관심을 높여 새로운 데옥시콜산 주사으로 이어질 수 있습니다. 이러한 시장경쟁은 제품특성, 가격대, 시장경쟁을 통한 혁신을 창출하고 선택사항이 늘어나면서 개업의와 소비자 모두에게 유리해지고 있습니다.

이러한 모든 개발이 데옥시콜산 주사 시장을 보다 다용도로 정확한 것으로 밀어 올리고 있습니다. 새로운 적응증, 개선된 제형, 디지털 계획 및 경쟁 강화는 보다 맞춤화되고 효율적인 비수술적 지방 감소 치료를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 데옥시콜산 주사 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• PESTLE 분석
• 특허 분석
• 규제 환경
• 업계의 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시 경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 데옥시콜산 주사 시장 동향(2019-2024년)과 예측(2025-2031년)
• 유형별
  • 10mg/mL : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)
• 용도별
  • 병원 : 동향과 예측(2019-2031년)
  • 클리닉 : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별
  • 용도별
  • 지역별
• 세계의 데옥시콜산 주사 시장 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 데옥시콜산 주사 시장 생산 능력 확대
  • 세계의 데옥시콜산 주사 시장 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• Allergan
• DEXLEVO
• Daewoong Pharmaceutical
• Merz Pharmaceuticals

영문목차

The future of the global deoxycholic acid injection market looks promising with opportunities in the hospital and clinic markets. The global deoxycholic acid injection market is expected to grow with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the increasing demand for non-surgical fat reduction, the rising popularity of aesthetic injectables, and the growing awareness of body contouring treatments.

• Lucintel forecasts that, within the type category, 10mg/mL will remain the largest segment over the forecast period.
• Within the application category, hospital will remain a larger segment.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Deoxycholic Acid Injection Market

The market for deoxycholic acid injection is rapidly growing, fueled by patient demand for minimally invasive approaches, technology, and increased awareness of its therapeutic uses. The trends are influencing product development in the future, clinical activities, and market forces, tending towards more individualized and efficient procedures.

• Expansion of Application Areas: Originally for submental fat, injections of deoxycholic acid are being used off-label with more frequency for other small, discrete fat deposits. This opens the market beyond the "double chin," providing a non-surgical solution for bra bulges, axillary fat, and inner thighs, making it more versatile and appealing to patients.
• Combination Therapies: There's increasing interest in using deoxycholic acid injections in combination with other aesthetic procedures such as cryolipolysis, radiofrequency, or skin tightening treatments. This combination treatment is designed to have a synergistic effect that boosts overall fat loss, enhances skin laxity, and delivers more extensive and more aesthetically successful body contouring outcomes for patients.
• Technological Development in Formulation: Research continues with an aim to enhance the formulation of deoxycholic acid injection for increased efficacy, lessened side effects, and maximum patient comfort. Developments in drug delivery technology and new active molecules, if any, are being investigated to provide more target-specific and effective fat loss with minimum treatment sessions.
• Individualized Treatment Plans: The trend in the market is moving toward very individualized treatment plans where the dose, injection method, and number of treatments are custom fit to a patient's specific anatomical needs and desired aesthetic goals. Customization maximizes results, enhances patient satisfaction, and reduces the potential for unwanted side effects, indicating a patient-oriented strategy.
• Greater Emphasis on Training and Education: With growing applications and novel methods, there's greater focus on extensive training and education for practitioners. This guarantees safe and effective administration and minimizes the occurrence of complications and enhances overall patient outcomes, which is important for market credibility and expansion.

These trends are all summing up to reshape the deoxycholic acid injection market in directions more adaptable, combined, and patient-focused. Treatment of more than one area, combinability with other modalities, and provision of personalized plans are creating greater market reach and innovation in treatment delivery and patient outcomes.

Recent Developments in the Deoxycholic Acid Injection Market

The market for deoxycholic acid injection is constantly developing with innovating advances focusing on increasing treatment effectiveness, patient safety, and wider availability. These are the dominant developments that represent the industry's reaction to increasing consumer interest in non-invasive body contouring and the quest for the best aesthetic results.

• Expanded Clinical Trials for New Indications: Initially approved for submental fat, expanding clinical trials are examining the use of deoxycholic acid for other small fat deposits. This effort aims at gaining regulatory clearance for more areas of treatment, thereby significantly broadening the potential market beyond the chin area alone and providing more full-body contouring solutions.
• Formulation and Delivery System Development: Companies are investing in R&D to develop deoxycholic acid products with better pharmacokinetic profiles or new delivery systems. This may result in less post-treatment swelling, quicker action onset, or fewer injection sites, ultimately improving patient comfort and satisfaction and simplifying the treatment process for practitioners.
• Integration of Digital Tools and AI for Treatment Planning: The use of artificial intelligence and digital imaging tools is a major advancement in the treatment planning of deoxycholic acid injections. These technologies make it possible to accurately map fat distribution and permit simulated outcome visualization, thus optimizing injection patterns for enhanced aesthetic outcomes and better patient understanding and expectations.
• Emergence of Off-Label Use and Doctor Expertise: Even with early restricted indications, there has been a trend in recent times among veteran doctors of employing deoxycholic acid injections off-label to address any number of localized reduction requirements. This evolution, stimulated through doctor expertise and demand, is opening the real-world use of the product and calling for stringent examination of safety procedures and anatomical understanding.
• Greater Competitive Market and Product Development: Whereas once controlled by a single product, the marketplace is experiencing greater interest from other pharmaceutical firms that can lead to new deoxycholic acid injectables. This marketplace competition is creating innovation through product characteristics, price point, and market competition that is advantageous to both practitioners and consumers with greater options.

All these developments are propelling the market for deoxycholic acid injections toward more versatility and accuracy. New indications, improved formulations, digital planning, and increased competitiveness are producing more customized and efficient non-surgical fat reduction treatments.

Strategic Growth Opportunities in the Deoxycholic Acid Injection Market

The deoxycholic acid injection market offers strong strategic growth opportunities by addressing anatomically specific regions and patient populations requiring non-surgical reduction in fat. Customizing marketing strategies and practitioner education toward these core applications can strongly enhance market penetration and treat multiple aesthetic concerns.

• Submental Fat Reduction: This is still the first and most proven use for deoxycholic acid injections. Growth potential exists in raising awareness among the general population, focusing on the non-surgical convenience, and highlighting long-term satisfaction to reach a larger portion of people annoyed by their "double chin" look.
• Bra Bulge and Axillary Fat Reduction: Addressing localized fat depots such as bra bulges and axillary fat is a key growth opportunity. Marketing should target women looking for better fit in clothing and greater body confidence, framing deoxycholic acid as a minimally invasive solution for these pesky, targeted areas.
• Inner Thigh Fat Reduction: Inner thigh fat reduction is another promising use. This is for those who want to minimize chafing and gain a more shapely leg look. Strategic development here is focusing on the cosmetic advantages and the non-surgical technique for a prevalent cosmetic issue.
• Jowl and Jawline Contouring: Although derivative of submental fat, precisely focusing on jowls and jawline definition has a separate opportunity. It is attractive for patients seeking a more defined facial contour and fresher look, placing deoxycholic acid in the hands of surgeons as a device for subtle yet efficacious facial remodeling.
• Therapy of Small Lipomas: Investigating the off-label use and prospects for official indications in the management of small, benign lipomas provides an interesting medical development opportunity. This fills a clinical gap where surgical removal could be too invasive, situating deoxycholic acid as a less invasive treatment option for suitable cases.

These strategic growth possibilities are affecting the deoxycholic acid injection market by fueling increased specialization and wider appeal. Through concentration on specific application areas, practitioners and manufacturers are able to create targeted solutions that address specific patient needs, increasing the size and relevance of the market beyond its original primary indication.

Deoxycholic Acid Injection Market Driver and Challenges

The deoxycholic acid injection market is influenced by an intricate balance of forces. These are the emerging demand for cosmetic improvements, advances in technology, and economic factors. It is essential that all stakeholders understand these because they influence market expansion, innovation, and regulation.

The factors responsible for driving the deoxycholic acid injection market include:

1. Growing Demand for Non-Surgical Treatments: A major stimulant is patients' increasing inclination towards less invasive aesthetic procedures in lieu of more conventional surgery based on reduced downtime, decreased risk, and equivalent outcomes. The trend positively supports demand for deoxycholic acid injections as an easily accessible substitute for liposuction.

2. Evolving Aesthetic Awareness: Being driven by social media and changing culture, people are more conscious about and concerned with their physical looks, such as certain fat pads. Increased aesthetic awareness promotes more individuals to undergo treatments for body contouring, such as deoxycholic acid injections.

3. Positive Clinical Results and Safety Profile: The documented efficacy and positive safety profile of deoxycholic acid injection for reduction of submental fat, shown by clinical trials, build the confidence of practitioners and patients alike. This helps toward greater acceptance and more adoption of the treatment.

4. Growing Practitioner Base: The increasing availability of aesthetic clinics and trained healthcare providers administering deoxycholic acid injections increases accessibility for prospective patients. With more practitioners skilled in the procedure, the availability and scope of the treatment increase, propelling market penetration.

5. Aging Population and Youthful Look Desire: The aging population worldwide is one of the major demographic drivers, as people look for solutions to reverse age-related changes, such as localized fat deposition. Deoxycholic acid injections provide a convenient method to treat these issues non-surgically, which appeals to the desire for a youthful look.

Challenges in the deoxycholic acid injection market are:

1. High Treatment Cost: The comparatively high cost per treatment session is a major impediment for certain patients and restricts the demand for deoxycholic acid injections. This price elasticity can affect patient adoption and overall market growth, especially in price-sensitive markets.

2. Need for Multiple Sessions: Multiple treatment sessions are often needed to achieve the best results, which may be labor-intensive and increase the total cost for patients. Such an extended treatment plan may result in patient dropout or dissatisfaction if expectations are not properly managed.

3. Risk of Side Effects and Patient Discomfort: Although safe, deoxycholic acid injection has temporary side effects including swelling, bruising, pain, and numbness at the site of injection. It is important to manage patient expectations around these fleeting discomforts to provide a good patient experience and sustain market reputation.

The deoxycholic acid injection market is driven mainly by high consumer demand for non-invasive aesthetics and established product effectiveness. Yet, the growth curve of the market is affected by price, requirement for multiple sessions, and possible side effects, requiring strategic pricing, patient education, and ongoing product development to keep the momentum going and extend appeal.

List of Deoxycholic Acid Injection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies deoxycholic acid injection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the deoxycholic acid injection companies profiled in this report include-

• Allergan
• DEXLEVO
• Daewoong Pharmaceutical
• Merz Pharmaceuticals

Deoxycholic Acid Injection Market by Segment

The study includes a forecast for the global deoxycholic acid injection market by type, application, and region.

Deoxycholic Acid Injection Market by Type [Value from 2019 to 2031]:

• 10mg/mL
• Others

Deoxycholic Acid Injection Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Others

Deoxycholic Acid Injection Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Deoxycholic Acid Injection Market

The deoxycholic acid injection market which is mainly utilized for non-surgical reduction of fat, is witnessing significant global trends. These trends are influenced by rising consumer demand for minimally invasive aesthetic treatments, coupled with continued research and regulatory developments. Important regions are witnessing marked progress in product take-up, production, and use.

• United States: The American market, in which Kybele (deoxycholic acid) was initially launched, continues to exhibit strong uptake as a result of high consumer familiarity with the product and an aggressive aesthetic medicine infrastructure. Recent trends involve optimizing injection methods for best effects and patient comfort, in addition to increased interest in off-label applications for other small fat deposits.
• China: China's fast-growing aesthetic market is fueling tremendous demand for deoxycholic acid injections. Advances are focused on building domestic production capacity for affordable solutions, in addition to incremental harmonization towards global quality and safety standards to address domestic demand as well as possible export.
• Germany: The German aesthetic market focuses on excellent quality in medical aesthetics, with priorities on product safety and quality. Recent advances include ongoing physician education on accurate injection techniques to guarantee effectiveness and reduce side effects, and investigations into combination therapies with other non-surgical fat reduction procedures.
• India: India's expanding middle class and rising aesthetic awareness are driving demand. More recent trends have included increased availability of deoxycholic acid injections in urban aesthetic clinics, and an emphasis on informing practitioners and consumers regarding the advantages and safety of this non-invasive fat reduction procedure.
• Japan: The market in Japan is all about precise aesthetic treatments and patient safety. Current advancements in deoxycholic acid injections are centered on extensive physician education to deliver precise and efficient treatment, and possibly investigating new formulations or modes of delivery to appeal to the choosy Japanese consumer.

Features of the Global Deoxycholic Acid Injection Market

• Market Size Estimates: Deoxycholic acid injection market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Deoxycholic acid injection market size by type, application, and region in terms of value ($B).
• Regional Analysis: Deoxycholic acid injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the deoxycholic acid injection market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the deoxycholic acid injection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the deoxycholic acid injection market by type (10mg/mL and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Deoxycholic Acid Injection Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Deoxycholic Acid Injection Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Deoxycholic Acid Injection Market by Type
  • 3.3.1: 10mg/mL: Trends and Forecast (2019 to 2031)
  • 3.3.2: Others: Trends and Forecast (2019 to 2031)
• 3.4: Global Deoxycholic Acid Injection Market by Application
  • 3.4.1: Hospital: Trends and Forecast (2019 to 2031)
  • 3.4.2: Clinic: Trends and Forecast (2019 to 2031)
  • 3.4.3: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Deoxycholic Acid Injection Market by Region
• 4.2: North American Deoxycholic Acid Injection Market
  • 4.2.1: North American Market by Type: 10mg/mL and Others
  • 4.2.2: North American Market by Application: Hospital, Clinic, and Others
  • 4.2.3: The United States Deoxycholic Acid Injection Market
  • 4.2.4: Mexican Deoxycholic Acid Injection Market
  • 4.2.5: Canadian Deoxycholic Acid Injection Market
• 4.3: European Deoxycholic Acid Injection Market
  • 4.3.1: European Market by Type: 10mg/mL and Others
  • 4.3.2: European Market by Application: Hospital, Clinic, and Others
  • 4.3.3: German Deoxycholic Acid Injection Market
  • 4.3.4: French Deoxycholic Acid Injection Market
  • 4.3.5: Spanish Deoxycholic Acid Injection Market
  • 4.3.6: Italian Deoxycholic Acid Injection Market
  • 4.3.7: The United Kingdom Deoxycholic Acid Injection Market
• 4.4: APAC Deoxycholic Acid Injection Market
  • 4.4.1: APAC Market by Type: 10mg/mL and Others
  • 4.4.2: APAC Market by Application: Hospital, Clinic, and Others
  • 4.4.3: Japanese Deoxycholic Acid Injection Market
  • 4.4.4: Indian Deoxycholic Acid Injection Market
  • 4.4.5: Chinese Deoxycholic Acid Injection Market
  • 4.4.6: South Korean Deoxycholic Acid Injection Market
  • 4.4.7: Indonesian Deoxycholic Acid Injection Market
• 4.5: ROW Deoxycholic Acid Injection Market
  • 4.5.1: ROW Market by Type: 10mg/mL and Others
  • 4.5.2: ROW Market by Application: Hospital, Clinic, and Others
  • 4.5.3: Middle Eastern Deoxycholic Acid Injection Market
  • 4.5.4: South American Deoxycholic Acid Injection Market
  • 4.5.5: African Deoxycholic Acid Injection Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Deoxycholic Acid Injection Market by Type
  • 6.1.2: Growth Opportunities for the Global Deoxycholic Acid Injection Market by Application
  • 6.1.3: Growth Opportunities for the Global Deoxycholic Acid Injection Market by Region
• 6.2: Emerging Trends in the Global Deoxycholic Acid Injection Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Deoxycholic Acid Injection Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Deoxycholic Acid Injection Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
  • Company Overview
  • Deoxycholic Acid Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: DEXLEVO
  • Company Overview
  • Deoxycholic Acid Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Daewoong Pharmaceutical
  • Company Overview
  • Deoxycholic Acid Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Merz Pharmaceuticals
  • Company Overview
  • Deoxycholic Acid Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing